[3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)

C53H36N4OPtSi — CID 162482835

About [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)

[3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+) (PubChem CID 162482835) has the molecular formula C53H36N4OPtSi and a molecular weight of 968.06 g/mol. Its IUPAC name is [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+).

Molecular Properties

• Compound Name: [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)
• PubChem CID: 162482835
• Molecular Formula: C53H36N4OPtSi
• Molecular Weight: 968.06 g/mol
• Exact Mass: 967.23
• IUPAC Name: [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)
• SMILES: CC1(C)c2cccnc2N(c2[c-]c([Si](c3[c-]c4c(cc3)c3ccccc3n3ccnc43)(c3ccccc3)c3ccccc3)ccc2)c2c1ccc1oc3ccccc3c21.[Pt+2]
• InChI: InChI=1S/C53H36N4OSi.Pt/c1-53(2)44-28-29-48-49(42-22-10-12-25-47(42)58-48)50(44)57(52-45(53)23-14-30-54-52)35-15-13-20-38(33-35)59(36-16-5-3-6-17-36,37-18-7-4-8-19-37)39-26-27-40-41-21-9-11-24-46(41)56-32-31-55-51(56)43(40)34-39;/h3-32H,1-2H3;/q-2;+2
• InChIKey: RMHOSUGXLGBNMR-UHFFFAOYSA-N
• XLogP: 10.02
• TPSA: 46.57 Ų
• H-Bond Acceptors: 5
• Rotatable Bonds: 5
• Heavy Atoms: 60
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	968.06
LogP ≤ 5	10.02
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	5

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)?

The IUPAC name of [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+) (CID 162482835) is [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+).

What is the SMILES notation for [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)?

The canonical SMILES for [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+) is CC1(C)c2cccnc2N(c2[c-]c([Si](c3[c-]c4c(cc3)c3ccccc3n3ccnc43)(c3ccccc3)c3ccccc3)ccc2)c2c1ccc1oc3ccccc3c21.[Pt+2].

What is the InChIKey of [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)?

The InChIKey is RMHOSUGXLGBNMR-UHFFFAOYSA-N. The full InChI is InChI=1S/C53H36N4OSi.Pt/c1-53(2)44-28-29-48-49(42-22-10-12-25-47(42)58-48)50(44)57(52-45(53)23-14-30-54-52)35-15-13-20-38(33-35)59(36-16-5-3-6-17-36,37-18-7-4-8-19-37)39-26-27-40-41-21-9-11-24-46(41)56-32-31-55-51(56)43(40)34-39;/h3-32H,1-2H3;/q-2;+2.

What are the key properties of [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+)?

[3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+) has a molecular weight of 968.06 g/mol, XLogP of 10.02, 5 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.

Where does this data come from?

All data for [3-(14,14-dimethyl-9-oxa-19,21-diazapentacyclo[11.8.0.02,10.03,8.015,20]henicosa-1(13),2(10),3,5,7,11,15(20),16,18-nonaen-21-yl)benzene-2-id-1-yl]-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;platinum(2+) is sourced from PubChem (CID 162482835), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).